2025 HCPCS Code C5278
Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
TAGS: additional primary wound infants greater total multiple thereof addition application substitute equal separately graft surfaceShort Description | Low cost skin substitute app |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Code Added Date | January 01, 2014 |
HCPCS Action Effective Date | January 01, 2014 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Type Of Service Code | 2 - Surgery |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9040 - Injection, fremanezumab-vfrm
- C9041 - Inj, coagulation factor xa
- C9042 - Inj., belrapzo 1 mg
- C9043 - Injection, levoleucovorin
- C9044 - Injection, cemiplimab-rwlc
- C9045 - Moxetumomab pasudotox-tdfk
- C9046 - Cocaine hcl nasal (goprelto)
- C9047 - Injection, caplacizumab-yhdp
- C9048 - Dexamethasone ophth insert
- C9049 - Injection, tagraxofusp-erzs
- C9050 - Injection, emapalumab-lzsg
- C9051 - Injection, omadacycline
- C9052 - Injection, ravulizumab-cwv
- C9053 - Inj, crizanlizumab-tmca
- C9054 - Injection, lefamulin
- C9055 - Inj, brexanolone
- C9056 - Injection, givosiran
- C9057 - Inj cetirizine hydrochloride
- C9058 - Injection,pegfilgrastim-bmez
- C9059 - Injection, meloxicam